Sentence examples for trial guidelines from inspiring English sources

Such studies should follow clinical trial guidelines from the International Headache Society [21, 22].

Therefore, detailed trial guidelines for study design and outcome parameters in the area of neuromodulation should be developed.

First, we briefly describe recent methodological developments, including consensus-based clinical trial guidelines for patient selection criteria, symptom assessment, and trial duration.

New studies are needed and these should be methodologically robust and follow the clinical trial guidelines from IHS in order to provide data for the rationale of CAM management in headache.

Third, although responses at 2 h are certainly clinically meaningful, are endorsed by the Clinical Trial Guidelines of the International Headache Society [6], and are accepted by the regulatory agencies, it is still not clear whether these endpoints are the most important for patients [7].

However, it is not clear if their treatment impacted headache frequency, which is our primary measure and the primary outcome recommended by the most recent IHS clinical trial guidelines [65], or other outcome measures such as those that we included, i.e., use of acute medications, disability burden and mood.

KG, SM, OT, LL, ZM and KB subsequently tested the draft instrument in trial guideline critical appraisal processes in the iCAHE Clinical Guidelines Clearinghouse.

While best developed for randomized, controlled trials, guidelines for other study types are being developed.

Based on the cardiovascular risks of pre-approval clinical trials, guidelines have been made to conduct cardiovascular safety outcome trials (CVSOTs) prior to the drug approval or after the drug has been approved.

Reporting of results should follow the Consolidated Standards for Reporting Trials guidelines and include secondary outcome measures to support or explain the primary outcome and an analysis of harms data.

Reporting of results should follow the Consolidated Standards for Reporting Trials guidelines and include an analysis of harms data and secondary outcome measures to support or explain the primary outcome.